The efficacy of anti-EGFR therapy in treating metastatic colorectal cancer differs between the middle/low rectum and the left-sided colon.

Kun-Han LeeWei-Shone ChenJeng-Kai JiangShung-Haur YangHuann-Sheng WangShih-Ching ChangYuan-Tzu LanChun-Chi LinHung-Hsin LinSheng-Chieh HuangHou-Hsuan ChengYee ChaoHao-Wei Teng

Published in: British journal of cancer (2021)

Anti-EGFR treatment has lower efficacy in metastatic middle/low rectal cancer than in left-sided colon cancer.

Keyphrases

small cell lung cancer
metastatic colorectal cancer
rectal cancer
epidermal growth factor receptor
tyrosine kinase
squamous cell carcinoma
locally advanced
stem cells
bone marrow
replacement therapy